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A monoclonal ntibody has been generated that interacts with the surface of cultured human aorta smooth 
muscle cells and does not bind to the endothelial cells from aorta and umbilical vein. An antigen recognized 
by the antibody has a molecular mass of 330 kDa as determined by electrophoresis of immunoprecipitate 
in SDS-polyacrylamide g l. The same antigen appeared to be present on the fibroblast surface while neither 
immunofluorescence, flowcytofluorimetry nor innnunoprecipitation reveal it on the endothelial cell surface 
or in the Triton X-100 extract. 
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1. INTRODUCTION 
Smooth muscle cells represent a large part of the 
cell population in the vascular wall. Abnormal 
proliferation and metabolic activity of these cells 
may be important in the pathogenesis of 
atherosclerosis [l-3]. Cultivation of smooth mus- 
cle cells is widely used as an approach to the study 
of metabolism and elements of contractile activity, 
as these cultured cells retain many of the 
biochemical properties characteristic of smooth 
muscle cells in the intact tissue [4-71. However, 
vascular smooth muscle cells growing in culture are 
‘phenotypically modulated’ according to certain 
criteria [8,9]. In addition to increased proliferative 
and biosynthetic activities they exhibit definite 
changes in the cytoskeleton and contractile ap- 
paratus: (a) desmin - the main compound of in- 
termediate filaments in muscle cells [lo] is removed 
by vimentin; (b) decreased amounts of both w 
actin and smooth muscle myosin are found in 
cultured smooth muscle cells of vascular origin 
[ 1 1 - 131. These in vitro changes may be relevant to 
the process of in vivo phenotypic modulation dur- 
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ing certain pathological processes such as 
atherosclerosis. Since practically all known 
markers of smooth muscle cells are compounds of 
cytoskeleton and contractile apparatus [ 12- 141 
they may not be revealed in ‘modulated cells’ in 
culture. 
In this report we present development and 
characterization of a monoclonal antibody that 
reacts with an antigen retained on the surface of 
cultured smooth muscle cells. The antigen has a 
molecular mass of 330 kDa and is localized on the 
surface of human aorta smooth muscle cells. En- 
dothelial cells do not contain the antigen as was 
shown by immunofluorescence, immunoprecipita- 
tion and flow cytofluorimetry. 
2. MATERIALS AND METHODS 
The culture of smooth muscle cells from tunica 
media of human aorta was obtained according to 
Ross [ 151. The cells were grown in Dulbecco’s 
modified Eagle’s medium (DMEM) supplemented 
with lo-15% human serum and 2-5070 cell free 
ascitic fluid obtained from the patient suffering 
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from heart failure. Endothelial cells from human 
umbilical vein (primary culture) and from human 
aorta (7th passage) were a generous gift of Dr S. 
Danilov (USSR Cardiology Research Center). 
Human smooth muscle cells of 6-8 passages were 
used for immunization procedures carried out as 
described in [16]. The first immunization was per- 
formed intraperitone~ly with lo6 cells per mouse. 
Hybridomas were obtained according to Kohler 
and M&stein [17]. Primary screening was per- 
formed by indirect immunofluorescence on living 
smooth muscle cells of 6-8 passages. Hybridoma 
supernatants were incubated with target cells for 
30 min at 37°C in COt-incubator. Fluorescein 
isothiocyanate (FITC) labeled antimouse IgG 
(Miles Scientific) diluted l-40 were used as the 
second layer antibodies. The washes were done 
with DMEM supplemented with 10% calf serum. 
The cells were postfixed in 4% form~dehyde 
prepared on phosphate buffered saline (PBS), 
mounted in 75010 glycerol on PBS and observed 
with a Zeiss Photomicroscope III. Selected 
A 
Fig. 1, Immunofluores~ent staining of living smooth muscle cells from human aorta with monoclonal antibody IIGIO. 
(a,b) Human aorta smooth muscle cells, (c,d) human umbilical vein endothelial cells, (a,c) immunofluorescence, (b,d) 
phase contrast. 
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hybridomas were cloned by limiting dilution in 
96-well culture plates. To obtain ascites about 10’ 
cells per mouse were injected intraperitoneally. In 
2-3 weeks ascitic fluid was collected and im- 
munoglobulins were precipitated by (N&)2S04 
(50% saturation). Precipitates were dissolved in 
0.2 M Na-borate buffer (pH 8.3) with 0.14 M 
NaCl, exhaustively dialyzed against the same 
buffer and stored frozen at -20°C. For flow 
cytofluorimetry, the cells were trypsinized gently 
and stained in suspension indirectly the same way 
as for immunofluorescence xcept that the incuba- 
tions and washes were performed at room 
temperature. The last 3 washes were done with 
serum and indicator free medium and the postfixa- 
tion step was omitted. Fluorescence was registered 
with a FACS II (Becton Dickinson, USA) 
cytofluorimeter. The wavelength of excitation light 
was 488 run. For antigen identification the cells 
were labeled with [35S]methionine (10 pCi/ml) for 
18 h and then extracted in 1% Triton X-100 in 
25 mM Tris-HCl buffer (pH 7.5, at 20°C) with 
3 mM EDTA, 2 mM EGTA and 0.5 mM PMSF 
for 15 min at 4°C. To the clarified extract 
50 pg/ml of primary (specific) antibodies were 
added together with gelatin up to 0.1% and NaCl 
up to 0.14 M. After 4 h incubation at 4”C, an- 
tibodies raised in rabbits against light chains of 
mouse immunoglobulins were added and in- 
cubated at 4°C for another 2 h. Finally, 200~1 of 
a 10% suspension of Staphylococcus aureus were 
added. After 1 h incubation at room temperature 
the precipitate formed was separated by cen- 
trifugation and analyzed electrophoretically [181. 
3. RESULTS AND DISCUSSION 
To obtain antibodies to antigen specific for the 
smooth muscle cell surface mice were immunized 
with cultivated smooth muscle cells from media of 
human aorta. Specificity of the antibodies secreted 
by hybridoma was determined by indirect im- 
munofluorescence technique. At first, the interac- 
tion of hybridoma supernatants with human 
smooth muscle cells was checked and then only 
those positive in this test were further examined on 
human skin fibroblasts and human umbilical cord 
endothelial cells. Culture supernatant from the 
well marked IIGlO appeared to contain antibodies 
reacting with the surface of living smooth muscle 
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Fig.2. Flow cytofluorimetric analysis of the interaction 
of IIGlO antibody with different cells. Smooth muscle 
cells from human aorta, 7th passage (a), human skin 
fibroblasts, 4th passage (b) or endothelial cells from 
human aorta, 7th passage (c) were incubated in 
suspension with 50pg/ml of antibody IIGlO (1) or 
nonimmune mouse immunoglobulins (2) followed by 
FITC-labeled secondary antibody (see section 2). 
cells (fig.1) and fibroblasts (not shown), while en- 
dothelial cells were not stained at all. The primary 
population was cloned, subcloned, stable clones 
were selected and propagated further in vivo. Im- 
munoglobulins (IgM, as determined serologically) 
obtained from the ascitic fluid exhibited the same 
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specificity as the culture supernatant. Reactivity of 
the IIGlO antibody with different cell types was ex- 
amined by means of flo,w cytofluorimetry. The 
data presented in fig.2 show that antibody IIGIO 
reacts with smooth muscle cells, and fibroblasts as 
well, but does not bind to endothelial cells from 
human aorta. In the latter case, relative 
fluorescence activity does not exceed nonspecific 
background binding of the second layer FITC- 
labeled antibodies to target cells. Antigen recog- 
nized by IIGlO antibody was identified by im- 
munoprecipitation. Fig.3 shows that im- 
munoprecipitate obtained from Triton X-100 ex- 
tract of smooth muscle cells in the presence of 
IIGlO antibody contains a polypeptide of 
330 kDa. The antigen molecule may contain lipid 
or carbohydrate constituents that would affect 
SDS binding and electrophoretic mobility. Thus, 
the molecular mass of the polypeptide may differ 
slightly from that determined by electrophoresis. 
Nevertheless, it seems that endothelial cells lack 
the antigen recognized by IIGlO antibody, since no 
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Fig.3. Autoradiograph of the SDS-polyacrylamide g l 
35 (515%) depicting S- labeled proteins in Triton X-100 
extracts and immunoprecipitates. (1) Triton X-100 
extract of human aorta smooth muscle cells; (2) 
immunoprecipitate, obtained from the extract of smooth 
muscle cells with the antibody IIGlO; (3) the same as (2), 
but nonimmune mouse immunoglobulins were added 
instead of the primary antibody; (4) Triton X-100 extract 
of human aorta endothelial cells; (5) immunoprecipitate, 
obtained from the extract of endothelial cells with the 
antibody IIGlO. 
bands were detected on an autoradiogram of the 
SDS gel where the sample containing immuno- 
precipitate of endothelial cell Triton X-100 extract 
was run (fig.3). Thus, the antibody described in 
this paper recognizes an antigen of molecular mass 
330 kDa localized on the surface of aorta smooth 
muscle cells and fibroblasts. The antigen was not 
detected in the endothelial cells. Distribution of the 
antigen in other tissues and cells has yet to be 
studied. But even now it is clear that antibody 
IIGlO exhibiting specificity demonstrated in these 
studies provides a good vector for the directed 
transport of substances to target (vascular smooth 
muscle) cells. 
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